Lucida Medical receives CE marking for Pi, its AI-machine learning software for detecting prostate cancer from MRI, enabling faster and more accurate
Lucida Medical receives CE marking for Pi, its AI-machine learning software for detecting prostate cancer from MRI, enabling faster and more accurate prostate cancer detectionCambridge, UK – 1st June 2021: Lucida Medical Ltd, the Cambridge, UK based start-up, has completed CE marking for its new machine learni...
Source: pharmiweb.com